Related references
Note: Only part of the references are listed.Uric acid levels predict survival in men with amyotrophic lateral sclerosis
Sabrina Paganoni et al.
JOURNAL OF NEUROLOGY (2012)
Protective effects of urate against 6-OHDA-induced cell injury in PC12 cells through antioxidant action
Ting-Ge Zhu et al.
NEUROSCIENCE LETTERS (2012)
The Origins of Oxidant Stress in Parkinson's Disease and Therapeutic Strategies
Dalton James Surmeier et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Serum uri acid: neuroprotection in thrombolysis. The Bergen NORSTROKE study
Nicola Logallo et al.
BMC NEUROLOGY (2011)
Variation in the Uric Acid Transporter Gene SLC2A9 and Its Association with AAO of Parkinson's Disease
Maurizio F. Facheris et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2011)
An exploratory study of serum urate levels in patients with amyotrophic lateral sclerosis
Stefano Zoccolella et al.
JOURNAL OF NEUROLOGY (2011)
Serum Urate and Probability of Dopaminergic Deficit in Early Parkinson's Disease
Michael A. Schwarzschild et al.
MOVEMENT DISORDERS (2011)
The Risk of Parkinson Disease Associated with Urate in a Community-Based Cohort of Older Adults
S. Jain et al.
NEUROEPIDEMIOLOGY (2011)
CAFFEINE AND URIC ACID MEDIATE GLUTATHIONE SYNTHESIS FOR NEUROPROTECTION
K. Aoyama et al.
NEUROSCIENCE (2011)
Uric acid and cognition in Parkinson's disease: A follow-up study
Tua Annanmaki et al.
PARKINSONISM & RELATED DISORDERS (2011)
Translational Stroke Research of the Combination of Thrombolysis and Antioxidant Therapy
Sergio Amaro et al.
STROKE (2011)
Plasma Urate and Parkinson's Disease in Women
Ellis J. O'Reilly et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2010)
Biomarker research in Parkinson's disease: objective measures needed for patient stratification in future cause-directed trials FOREWORD
Michael G. Schlossmacher et al.
BIOMARKERS IN MEDICINE (2010)
Urate: a novel biomarker of Parkinson's disease risk, diagnosis and prognosis
S. Cipriani et al.
BIOMARKERS IN MEDICINE (2010)
The Relationship Between Uric Acid Levels and Huntington's Disease Progression
Peggy Auinger et al.
MOVEMENT DISORDERS (2010)
Higher Serum Uric Acid Associated with Decreased Parkinson's Disease Prevalence in a Large Community-Based Survey
Andrea Winquist et al.
MOVEMENT DISORDERS (2010)
Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1
Jaime N. Guzman et al.
NATURE (2010)
Rasagiline, Parkinson neuroprotection, and delayed-start trials Still no satisfaction?
J. Eric Ahlskog et al.
NEUROLOGY (2010)
Treating gout with pegloticase, a PEGylated urate oxidase, provides insight into the importance of uric acid as an antioxidant in vivo
Michael S. Hershfield et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Plasma Urate and Parkinson's Disease in the Atherosclerosis Risk in Communities (ARIC) Study
Honglei Chen et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2009)
Urate as a Predictor of the Rate of Clinical Decline in Parkinson Disease
Alberto Ascherio et al.
ARCHIVES OF NEUROLOGY (2009)
Multiple roles for nicotine in Parkinson's disease
Maryka Quik et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Oxidative and nitrosative stress in Parkinson's disease
Anthony H. K. Tsang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
Serum uric acid and cognitive function and dementia
S. M. Euser et al.
BRAIN (2009)
Serum uric acid levels in patients with Parkinson's disease: Their relationship to treatment and disease duration
Elisabeth Andreadou et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2009)
Protection of midbrain dopaminergic neurons by the end-product of purine metabolism uric acid: potentiation by low-level depolarization
Serge Guerreiro et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Low uric acid levels in serum of patients with ALS: Further evidence for oxidative stress?
D. Keizman et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Neuroprotection Trials in Parkinson's Disease: Systematic Review
Robert G. Hart et al.
MOVEMENT DISORDERS (2009)
Plasma Urate and Progression of Mild Cognitive Impairment
Michael C. Irizarry et al.
NEURODEGENERATIVE DISEASES (2009)
Interplay between Cytosolic Dopamine, Calcium, and α-Synuclein Causes Selective Death of Substantia Nigra Neurons
Eugene V. Mosharov et al.
NEURON (2009)
A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
C. Warren Olanow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Diet, urate, and Parkinson's disease risk in men
Xiang Gao et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Serum urate as a predictor of clinical and radiographic progression in Parkinson disease
Michael A. Schwarzschild et al.
ARCHIVES OF NEUROLOGY (2008)
Gout and the Risk of Parkinson's Disease: A Cohort Study
Mary De Vera et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Metabolomic profiling to develop blood biomarkers for Parkinson's disease
Mikhail Bogdanov et al.
BRAIN (2008)
Uric acid associates with cognition in Parkinson's disease
Tua Annanmaki et al.
PARKINSONISM & RELATED DISORDERS (2008)
Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis
Claire Henchcliffe et al.
NATURE CLINICAL PRACTICE NEUROLOGY (2008)
Altered uric acid levels and disease states
Melinda K. Kutzing et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Gout and risk of Parkinson disease -: A prospective study
Alvaro Alonso et al.
NEUROLOGY (2007)
Plasma urate and risk of Parkinson's disease
M. G. Weisskopf et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Clinical trials for neuroprotection in Parkinson's disease: overcoming angst and futility?
Albert Y. Hung et al.
CURRENT OPINION IN NEUROLOGY (2007)
Low plasma uric acid level in Parkinson's disease
Tua Annanmaki et al.
MOVEMENT DISORDERS (2007)
Astroglia-mediated effects of uric acid to protect spinal cord neurons from glutamate toxicity
Yangzhou Du et al.
GLIA (2007)
Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke
Eduardo Romanos et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Impairment of the ability of the injured aged brain in elevating urate and ascorbate
E Moor et al.
EXPERIMENTAL GERONTOLOGY (2006)
Serum uric acid levels and the risk of Parkinson disease
LML de Lau et al.
ANNALS OF NEUROLOGY (2005)
Interactions of peroxynitrite with uric acid in the presence of ascorbate and thiols: Implications for uncoupling endothelial nitric oxide synthase
N Kuzkaya et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Inosine reduces ischemic brain injury in rats
H Shen et al.
STROKE (2005)
Uric acid protects against secondary damage after spinal cord injury
GS Scott et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Biomarkers of antioxidant capacity in the hydrophilic and lipophilic compartments of human plasma
KJ Yeum et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2004)
Plasma antioxidant status, immunoglobulin G oxidation and lipid peroxidation in demented patients: Relevance to Alzheimer disease and vascular dementia
MC Polidori et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2004)
Neuroprotective agents for clinical trials in Parkinson's disease - A systematic assessment
BM Ravina et al.
NEUROLOGY (2003)
Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease
P Rinaldi et al.
NEUROBIOLOGY OF AGING (2003)
Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors
GS Scott et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induces apoptosis in mouse nigrostriatal glia - Relevance to nigral neuronal death and striatal neurochemical changes
PA Serra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Peroxidase properties of extracellular superoxide dismutase - Role of uric acid in modulating in vivo activity
HU Hink et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Inosine induces axonal rewiring and improves behavioral outcome after stroke
P Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic, neurons in models of Parkinson's disease
W Duan et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers
WS Waring et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2001)
The role of uric acid in protection against peroxynitrite-mediated pathology
GS Scott et al.
MEDICAL HYPOTHESES (2001)
Dopamine-induced apoptosis is mediated by oxidative stress and is enhanced by cyanide in differentiated PC12 cells
DC Jones et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Share Paper
